The global scramble for critical minerals has cast a spotlight on a metal long overshadowed by lithium and rare earths. Wolfram — essential for semiconductors, defense hardware, and industrial cutting tools — is now commanding attention, and Almonty Industries is riding that wave. The company’s stock has surged nearly 149% since January, though last week saw a modest pullback as investors locked in profits.
The China Factor and Sangdong’s Promise
China’s stranglehold on the wolfram market is tightening. The country controls roughly 88% of global supply, a dominance that has rattled Western supply chains. Japanese component suppliers recently warned Samsung and SK Hynix about potential shortages of tungsten hexafluoride, a critical gas for chip manufacturing. Meanwhile, the U.S. defense sector faces a hard deadline: from 2027, American arms makers must source wolfram from non-Chinese sources.
Almonty’s Sangdong mine in South Korea is positioned as the answer. Phase 1 is complete, with the processing plant handling around 640,000 tonnes of ore annually and producing roughly 2,300 tonnes of wolfram concentrate. The company plans to double that capacity by 2027, a move that could satisfy about 40% of global wolfram demand outside China. With a mine life exceeding 45 years, Sangdong is no short-term play.
Financial Reality Check
The numbers tell a story of transformation — and growing pains. Almonty’s revenue climbed 13% in 2025 to 32.5 million Canadian dollars, a first taste of what full-scale production can deliver. The headline net loss of 161.9 million CAD, however, looks alarming. But dig deeper: 87.3 million CAD of that is a non-cash revaluation of derivative liabilities tied to convertible bonds, leaving the operating business and cash position unscathed.
The company’s balance sheet is robust. Almonty ended 2025 with 268.4 million CAD in cash, bolstered by a heavily oversubscribed U.S. initial public offering raising 90 million dollars and a follow-on financing of 129 million dollars late last year. The relocation of its corporate headquarters from Toronto to Dillon, Montana, underscores a strategic pivot toward Western supply chains.
Should investors sell immediately? Or is it worth buying Almonty?
Analyst Optimism Meets Technical Overheating
The stock closed last Friday at 29.94 Canadian dollars on the TSX, down about 7% on the week. The relative strength index sits at 76.7, firmly in overbought territory. The 50-day moving average of 24.77 CAD and the 200-day average of 13.58 CAD both trail far below the current price, underscoring just how steep the rally has been.
Despite the pullback, analysts remain bullish. Texas Capital initiated coverage this week with a buy rating and a price target of 25 U.S. dollars. DA Davidson echoed that target. The consensus rating stands at “Moderate Buy,” with four buy recommendations, one strong buy, and one sell. The key catalyst ahead: Almonty’s first full quarter of production data, due in May. That report will provide the market with its first concrete evidence of Sangdong’s operational efficiency.
The Risk-Reward Calculus
For investors, the equation is clear. The underlying story — a Western-aligned wolfram producer with a world-class asset, a strong cash position, and a strategic tailwind from defense and chip supply chains — is compelling. The APT wolfram price has surged 534% over the past twelve months to around 2,250 U.S. dollars per metric tonne, with spot prices adding another 50% since January 2026 alone.
Yet the stock carries annualized volatility above 100%. Technical support zones sit around 28.50 and 25.00 CAD on the TSX; a break below those levels would trigger sell signals. The rally has been extraordinary, but the question now is whether the fundamentals can catch up with the valuation. The May production data will go a long way toward answering that.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from April 25 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
Almonty: Buy or sell? Read more here...
